PMDA drug package insert

リシノプリル錠5mg「トーワ」

PMDA Prescription drug · 東和薬品株式会社 · package insert Sep 9, 2025

Key facts

Brand names リシノプリル錠5mg「トーワ」, リシノプリル錠10mg「トーワ」, リシノプリル錠20mg「トーワ」
Nonproprietary names リシノプリル水和物
Companies 製造販売元/東和薬品株式会社
Product type Prescription drug
Therapeutic category 持続性ACE阻害剤
Therapeutic category codes 872144, 872179
YJ codes 2144006F1057, 2144006F2118, 2144006F3041
Approval numbers 22100AMX02147, 21900AMX01612, 22100AMX02021
Package insert edition 第2版
Package insert date Sep 9, 2025
PMDA document key 480235_2144006F1057_1
PMDA company code 480235

At a glance

  • 1–9 Package insert revisions
  • 10–99 Related PMDA documents
  • 1–9 Safety communications
  • No PMDA review report published
  • No Risk management plan (RMP)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMDA approved drugs and package inserts (Japan)

Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date:

Browse all PMDA approved drugs and package inserts (Japan)